Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD1653 |
Approved |
0.8718 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8344 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8219 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8207 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8176 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8144 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8092 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8036 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8027 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8012 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7941 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7917 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7818 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7805 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7785 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7758 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7679 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD5494 |
Approved |
0.764 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7633 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD37 |
Approved |
0.76 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD3750 |
Approved |
0.759 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD4966 |
Approved |
0.759 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7578 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7457 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7453 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7412 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.74 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7399 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7240 |
Approved |
0.733 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7325 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7312 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7308 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7237 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4749 |
Approved |
0.72 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7193 |
Intermediate Similarity |
NPD919 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7158 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7143 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7103 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7066 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7066 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7052 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7021 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7005 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD4675 |
Approved |
0.6982 |
Remote Similarity |
NPD4678 |
Approved |
0.6975 |
Remote Similarity |
NPD5762 |
Approved |
0.6975 |
Remote Similarity |
NPD5763 |
Approved |
0.6975 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6971 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6957 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6932 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD3226 |
Approved |
0.6919 |
Remote Similarity |
NPD5353 |
Approved |
0.6918 |
Remote Similarity |
NPD4140 |
Approved |
0.6918 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1240 |
Approved |
0.6915 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6032 |
Approved |
0.6914 |
Remote Similarity |
NPD6100 |
Approved |
0.6914 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD6099 |
Approved |
0.6903 |
Remote Similarity |
NPD1203 |
Approved |
0.6902 |
Remote Similarity |
NPD6842 |
Approved |
0.6902 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6902 |
Remote Similarity |
NPD6841 |
Approved |
0.6902 |
Remote Similarity |
NPD7906 |
Approved |
0.6899 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD4536 |
Approved |
0.6894 |
Remote Similarity |
NPD4538 |
Approved |
0.6894 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1358 |
Approved |
0.6875 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD1535 |
Discovery |
0.6863 |
Remote Similarity |
NPD3705 |
Approved |
0.6863 |
Remote Similarity |
NPD1611 |
Approved |
0.6859
|
Remote Similarity |
NPD6584 |
Phase 3 |